Locke Bio Launches Locke Bio Pay

Locke Bio Launches Locke Bio Pay, Enabling Compliant Payment Processing for Entire Telehealth Industry

New solution enables any telehealth company or online pharmacy to process payments compliantly, backed by authorized banks, independent of Locke Bio's full software platform

LOS ANGELES, CA -- Locke Bio, a digital health platform company, today announced the launch of Locke Bio Pay, a standalone payment processing solution designed specifically for the telehealth industry. Locke Bio Pay allows any telehealth or online pharmacy company to compliantly process payments through banks authorized to underwrite for prescription medication sales online, without needing to use Locke Bio's full white-label software platform.

Locke Bio Pay is built on top of the company's partnerships with chartered banks authorized for telehealth and prescription payment processing. There are only a handful of banks in the U.S. allowed to process payments for online prescription sales. Locke Bio Pay connects to these authorized banks on the backend, providing a simple, one-click checkout page that telehealth companies can use to ensure regulatory compliance.

"Compliance is one of the biggest challenges in the telehealth space. Most payment processors are not equipped to handle the unique regulatory requirements for online prescription sales," said Cathy Tie, CEO of Locke Bio. "With Locke Bio Pay, we're using our deep expertise in digital health compliance to create a simple, plug-and-play solution any company can use, while leveraging our backend integrations with properly chartered banks. "The new standalone service expands upon Locke Bio's existing partnership with LegitScript, which provides certification and monitoring for online pharmacies to accept credit card payments. Locke Bio is an end-to-end software platform with LegitScript partnership and has helped over 80 companies obtain LegitScript certification to date.

"Regulatory compliance is critical for telehealth companies looking to operate responsibly and sustainably," said Michal Conley, General Manager of LegitScript Certification. "Locke Bio Pay’s approach supports efforts to help ensure that payments for prescription medications are processed through properly vetted financial institutions, which is an important component of an overall compliance strategy for online healthcare businesses."

Locke Bio has already made strides in bringing compliant payment processing to telehealth through its full-service platform. "We've helped some of the largest telehealth brands compliantly process hundreds of millions in payment volume on our full platform," said Tie. "Now with Locke Bio Pay, we're excited to extend that compliance infrastructure as an affordable standalone service to support the entire industry and fuel continued innovation in digital health."

To learn more about Locke Bio Pay, visit https://lockebio.com/payments or contact info@lockebio.com.

About Locke Bio

Locke Bio is a digital health platform company dedicated to helping enterprises compliantly launch telehealth and online pharmacy solutions. Locke Bio offers a full white-labeled platform with patient onboarding, customized e-commerce websites, doctor consultations, prescription fulfillment, and more, as well as the standalone Locke Bio Pay compliant payment processing

solution. Locke Bio's offerings are powered by a network of licensed doctors, pharmacies, and banks across the U.S. and Canada. To learn more, visit https://lockebio.com.

‍